FDA Removes Pacira Warning Letter Amid Free Speech Suit
The U.S. Food and Drug Administration has quietly unpublished a warning letter objecting to the promotional practices of Pacira Pharmaceuticals Inc., an unusual step that follows the drugmaker's constitutional challenge to...To view the full article, register now.
Already a subscriber? Click here to view full article